OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $665.80 million. The enterprise value is $731.10 million.
| Market Cap | 665.80M |
| Enterprise Value | 731.10M |
Important Dates
The last earnings date was Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 26.11 million shares outstanding. The number of shares has increased by 1.98% in one year.
| Current Share Class | 26.11M |
| Shares Outstanding | 26.11M |
| Shares Change (YoY) | +1.98% |
| Shares Change (QoQ) | +1.54% |
| Owned by Insiders (%) | 6.52% |
| Owned by Institutions (%) | 66.18% |
| Float | 17.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.63 |
| Forward PS | 2.36 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 4.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 89.88 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.32.
| Current Ratio | 4.78 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 23.05 |
| Debt / FCF | n/a |
| Interest Coverage | -2.72 |
Financial Efficiency
Return on equity (ROE) is -11.36% and return on invested capital (ROIC) is -3.11%.
| Return on Equity (ROE) | -11.36% |
| Return on Assets (ROA) | -2.80% |
| Return on Invested Capital (ROIC) | -3.11% |
| Return on Capital Employed (ROCE) | -4.97% |
| Weighted Average Cost of Capital (WACC) | 9.04% |
| Revenue Per Employee | $419,807 |
| Profits Per Employee | -$65,990 |
| Employee Count | 602 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 0.51 |
Taxes
In the past 12 months, OrthoPediatrics has paid $278,000 in taxes.
| Income Tax | 278,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.88% in the last 52 weeks. The beta is 0.97, so OrthoPediatrics's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +32.88% |
| 50-Day Moving Average | 20.33 |
| 200-Day Moving Average | 18.06 |
| Relative Strength Index (RSI) | 79.64 |
| Average Volume (20 Days) | 218,103 |
Short Selling Information
The latest short interest is 839,134, so 3.21% of the outstanding shares have been sold short.
| Short Interest | 839,134 |
| Short Previous Month | 881,263 |
| Short % of Shares Out | 3.21% |
| Short % of Float | 4.79% |
| Short Ratio (days to cover) | 5.66 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $252.72 million and -$39.73 million in losses. Loss per share was -$1.67.
| Revenue | 252.72M |
| Gross Profit | 186.14M |
| Operating Income | -22.77M |
| Pretax Income | -39.45M |
| Net Income | -39.73M |
| EBITDA | -445,000 |
| EBIT | -22.77M |
| Loss Per Share | -$1.67 |
Balance Sheet
The company has $45.88 million in cash and $111.18 million in debt, with a net cash position of -$65.30 million or -$2.50 per share.
| Cash & Cash Equivalents | 45.88M |
| Total Debt | 111.18M |
| Net Cash | -65.30M |
| Net Cash Per Share | -$2.50 |
| Equity (Book Value) | 343.61M |
| Book Value Per Share | 13.16 |
| Working Capital | 199.66M |
Cash Flow
In the last 12 months, operating cash flow was $7.41 million and capital expenditures -$9.24 million, giving a free cash flow of -$1.84 million.
| Operating Cash Flow | 7.41M |
| Capital Expenditures | -9.24M |
| Depreciation & Amortization | 22.33M |
| Net Borrowing | -1.76M |
| Free Cash Flow | -1.84M |
| FCF Per Share | -$0.07 |
Margins
Gross margin is 73.65%, with operating and profit margins of -9.01% and -15.72%.
| Gross Margin | 73.65% |
| Operating Margin | -9.01% |
| Pretax Margin | -15.61% |
| Profit Margin | -15.72% |
| EBITDA Margin | -0.18% |
| EBIT Margin | -9.01% |
| FCF Margin | n/a |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.98% |
| Shareholder Yield | -1.98% |
| Earnings Yield | -5.97% |
| FCF Yield | -0.28% |
Analyst Forecast
The average price target for OrthoPediatrics is $26.67, which is 4.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $26.67 |
| Price Target Difference | 4.59% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 12.17% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 1.66 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.66 |
| Piotroski F-Score | 4 |